{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8953423", "DateCompleted": {"Year": "1997", "Month": "03", "Day": "10"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "30"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0378-8741", "JournalIssue": {"Volume": "54", "Issue": "2-3", "PubDate": {"Year": "1996", "Month": "Nov"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Extracts from rhizomes of Cyperus articulatus (Cyperaceae) displace [3H]CGP39653 and [3H]glycine binding from cortical membranes and selectively inhibit NMDA receptor-mediated neurotransmission.", "Pagination": {"StartPage": "103", "EndPage": "111", "MedlinePgn": "103-11"}, "Abstract": {"AbstractText": ["The marshland plant Cyperus articulatus (Cyperaceae) is commonly used in traditional medicine in Africa and Latin America to treat a wide variety of human diseases ranging from headache to epilepsy. We tested the hypothesis that the purported anti-epileptic effect of this plant might be due to a functional inhibition of excitatory amino acid receptors. One or several component(s) contained in the extracts inhibited the binding of [3H]CGP39653 to the NMDA recognition site and of [3H]glycine to the strychnine-insensitive glycine site of the NMDA receptor complex from rat neocortex. Water extracts from rhizomes of Cyperus articulatus dose-dependently reduced spontaneous epileptiform discharges and NMDA-induced depolarizations in the rat cortical wedge preparation at concentrations at which AMPA-induced depolarizations were not affected. We conclude that the purported beneficial effects of Cyperus articulatus might at least partially be due to inhibition of NMDA-mediated neurotransmission."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sandoz Research Institute Berne Ltd., Switzerland."}], "LastName": "Bum", "ForeName": "E N", "Initials": "EN"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Meier", "ForeName": "C L", "Initials": "CL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Urwyler", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wang", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Herrling", "ForeName": "P L", "Initials": "PL"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Excitatory Amino Acid Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperazines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, N-Methyl-D-Aspartate"}, {"RegistryNumber": "10028-17-8", "NameOfSubstance": "Tritium"}, {"RegistryNumber": "132472-31-2", "NameOfSubstance": "CGP 39653"}, {"RegistryNumber": "137424-80-7", "NameOfSubstance": "SDZ EAA 494"}, {"RegistryNumber": "76726-92-6", "NameOfSubstance": "2-Amino-5-phosphonovalerate"}, {"RegistryNumber": "TE7660XO1C", "NameOfSubstance": "Glycine"}], "MeshHeadingList": [{"QualifierName": ["analogs & derivatives", "metabolism", "pharmacology"], "DescriptorName": "2-Amino-5-phosphonovalerate"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": [], "DescriptorName": "Binding, Competitive"}, {"QualifierName": ["drug effects", "physiology", "ultrastructure"], "DescriptorName": "Cerebral Cortex"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Excitatory Amino Acid Antagonists"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Glycine"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects", "physiology", "ultrastructure"], "DescriptorName": "Membranes"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Piperazines"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["antagonists & inhibitors", "metabolism", "physiology"], "DescriptorName": "Receptors, N-Methyl-D-Aspartate"}, {"QualifierName": ["drug effects"], "DescriptorName": "Synaptic Transmission"}, {"QualifierName": [], "DescriptorName": "Tritium"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1996", "Month": "11", "Day": "1"}, {"Year": "1996", "Month": "11", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "11", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8953423", "10.1016/s0378-8741(96)01453-5", "S0378-8741(96)01453-5"]}}]}